Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- A1901 Q-VD-OPh53 CitationTarget: CaspasesSummary: Cell-permeable, irreversible pan-caspase inhibitor
- A1903 E 64d4 CitationSummary: Cysteine protease inhibitor
- A1904 Boc-D-FMK1 CitationTarget: CaspasesSummary: Pan-caspase inhibitor
- A4355 Tosedostat (CHR2797)1 CitationTarget: AminopeptidasesSummary: Aminopeptidase inhibitor
- A1920 Z-DEVD-FMK12 CitationTarget: CaspasesSummary: Caspase-3 inhibitor
- A4386 Elesclomol (STA-4783)3 CitationSummary: Oxidative stress/apoptosis inducer,potent and novel
- A4388 XL-8881 CitationTarget: HSP90Summary: Hsp90 inhibitor
- A1926 CA 0742 CitationTarget: CathepsinsSummary: Cathepsin B inhibitor
- A8162 E-64-cTarget: cysteine proteaseSummary: Inhibitor of cysteine proteinases
- A8165 Q-VD(OMe)-OPh6 CitationTarget: CaspasesSummary: Pan-caspase inhibitor